BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 23478874)

  • 1. Variation in the use of diuretic therapy for infants with bronchopulmonary dysplasia.
    Slaughter JL; Stenger MR; Reagan PB
    Pediatrics; 2013 Apr; 131(4):716-23. PubMed ID: 23478874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sildenafil Treatment of Infants With Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension.
    Backes CH; Reagan PB; Smith CV; Jadcherla SR; Slaughter JL
    Hosp Pediatr; 2016 Jan; 6(1):27-33. PubMed ID: 26666265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loop Diuretics in Severe Bronchopulmonary Dysplasia: Cumulative Use and Associations with Mortality and Age at Discharge.
    Bamat NA; Nelin TD; Eichenwald EC; Kirpalani H; Laughon MM; Jackson WM; Jensen EA; Gibbs KA; Lorch SA
    J Pediatr; 2021 Apr; 231():43-49.e3. PubMed ID: 33152371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diuretic exposure in premature infants from 1997 to 2011.
    Laughon MM; Chantala K; Aliaga S; Herring AH; Hornik CP; Hughes R; Clark RH; Smith PB
    Am J Perinatol; 2015 Jan; 32(1):49-56. PubMed ID: 24801161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variability in duration of outpatient diuretic therapy in bronchopulmonary dysplasia: a clinical experience.
    Bhandari A; Chow U; Hagadorn JI
    Am J Perinatol; 2010 Aug; 27(7):529-35. PubMed ID: 20178069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled bronchodilator use for infants with bronchopulmonary dysplasia.
    Slaughter JL; Stenger MR; Reagan PB; Jadcherla SR
    J Perinatol; 2015 Jan; 35(1):61-6. PubMed ID: 25102319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized trial of long-term diuretic therapy for infants with oxygen-dependent bronchopulmonary dysplasia.
    Kao LC; Durand DJ; McCrea RC; Birch M; Powers RJ; Nickerson BG
    J Pediatr; 1994 May; 124(5 Pt 1):772-81. PubMed ID: 8176568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medication use in infants with severe bronchopulmonary dysplasia admitted to United States children's hospitals.
    Bamat NA; Kirpalani H; Feudtner C; Jensen EA; Laughon MM; Zhang H; Monk HM; Passarella M; Lorch SA
    J Perinatol; 2019 Sep; 39(9):1291-1299. PubMed ID: 31227785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilization of inhaled corticosteroids for infants with bronchopulmonary dysplasia.
    Slaughter JL; Stenger MR; Reagan PB; Jadcherla SR
    PLoS One; 2014; 9(9):e106838. PubMed ID: 25192252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postnatal diuretics, weight gain and home oxygen requirement in extremely preterm infants.
    Williams EE; Gunawardana S; Donaldson NK; Dassios T; Greenough A
    J Perinat Med; 2022 Jan; 50(1):100-107. PubMed ID: 34265878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled bronchodilator exposure in the management of bronchopulmonary dysplasia in hospitalized infants.
    Euteneuer JC; Kerns E; Leiting C; McCulloh RJ; Peeples ES
    J Perinatol; 2021 Jan; 41(1):53-61. PubMed ID: 32759956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diuretic Tolerance to Repeated-Dose Furosemide in Infants Born Very Preterm with Bronchopulmonary Dysplasia.
    Bamat NA; Huber M; Shults J; Li Y; Zong Z; Zuppa A; Eichenwald EC; Laughon MM; DeMauro SB; McKenna KJ; Laskin B; Lorch SA
    J Pediatr; 2024 Mar; 266():113813. PubMed ID: 37918519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary effect of inhaled furosemide in ventilated infants with severe bronchopulmonary dysplasia.
    Kugelman A; Durand M; Garg M
    Pediatrics; 1997 Jan; 99(1):71-5. PubMed ID: 8989341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aerosolized diuretics for preterm infants with (or developing) chronic lung disease.
    Brion LP; Primhak RA; Yong W
    Cochrane Database Syst Rev; 2000; (2):CD001694. PubMed ID: 10796271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diuretics acting on the distal renal tubule for preterm infants with (or developing) chronic lung disease.
    Brion LP; Primhak RA; Ambrosio-Perez I
    Cochrane Database Syst Rev; 2000; (3):CD001817. PubMed ID: 10908511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous or enteral loop diuretics for preterm infants with (or developing) chronic lung disease.
    Brion LP; Primhak RA
    Cochrane Database Syst Rev; 2000; (4):CD001453. PubMed ID: 11034718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous or enteral loop diuretics for preterm infants with (or developing) chronic lung disease.
    Brion LP; Primhak RA
    Cochrane Database Syst Rev; 2000; (2):CD001453. PubMed ID: 10796264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of oral diuretics on pulmonary mechanics in infants with chronic bronchopulmonary dysplasia: results of a double-blind crossover sequential trial.
    Kao LC; Warburton D; Cheng MH; Cedeño C; Platzker AC; Keens TG
    Pediatrics; 1984 Jul; 74(1):37-44. PubMed ID: 6377221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled Corticosteroid Exposure in Hospitalized Infants with Bronchopulmonary Dysplasia.
    Leiting C; Kerns E; Euteneuer JC; McCulloh RJ; Peeples ES
    Am J Perinatol; 2024 May; 41(S 01):e85-e93. PubMed ID: 35523409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diuretics acting on the distal renal tubule for preterm infants with (or developing) chronic lung disease.
    Brion LP; Primhak RA; Ambrosio-Perez I
    Cochrane Database Syst Rev; 2000; (2):CD001817. PubMed ID: 10796274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.